Carregant...
Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation
OBJECTIVE: To compare the cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in patients with atrial fibrillation (AF). METHODS: Using standard methods, we created a Markov decision model based on the estimated cost of apixaban and data from the Apixaban for Reduction in Stro...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3525294/ https://ncbi.nlm.nih.gov/pubmed/22993279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e31826d5fe8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|